| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 789.734 | 94 |
| GSM780708 | Untreated after 4 days (C2_1) | 789.734 | 94 |
| GSM780709 | Untreated after 4 days (C3_1) | 820.214 | 95 |
| GSM780719 | Untreated after 4 days (C1_2) | 723.781 | 94 |
| GSM780720 | Untreated after 4 days (C2_2) | 778.049 | 94 |
| GSM780721 | Untreated after 4 days (C3_2) | 838.748 | 95 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 929.104 | 95 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 829.526 | 95 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 963.421 | 95 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 979.107 | 95 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 1046.41 | 96 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 888.772 | 95 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 1087.81 | 96 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 752.673 | 94 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 915.483 | 95 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 977.319 | 95 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 765.414 | 94 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 945.529 | 95 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 807.91 | 95 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 781.764 | 94 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 789.734 | 94 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 804.716 | 94 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 862.606 | 95 |